Physician-researchers from the Cardiac Center at Children's Hospital of Philadelphia (CHOP) presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2016 in New Orleans.
Eosinophilic esophagitis involves chronic allergic inflammation with tissue damage leading to fibrosis. The goal of the Muir Lab is to elucidate the mechanisms of esophageal fibrosis and to improve its therapeutic and diagnostic approaches.
Translating treatment guidelines into structured care plans for gastrointestinal motility patients and using precision medicine to develop new therapies and treatment strategies, all with the goal of improving outcomes for children.
